Zubsolv Európska únia - slovenčina - EMA (European Medicines Agency)

zubsolv

accord healthcare s.l.u. - buprenorphine hydrochloride, naloxone hydrochloride dihydrate - poruchy súvisiace s opiátmi - Ďalšie lieky na nervový systém - substitučná liečba závislosti od opiátov v rámci lekárskej, sociálnej a psychologickej liečby. zámerom naloxónovej zložky je zabrániť intravenóznemu zneužitiu. liečba je určená na použitie u dospelých a dospievajúcich nad 15 rokov, ktorí súhlasili s liečbou závislosti.

Zypsilan 20 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zypsilan 20 mg

krka, d.d., novo mesto, slovinsko - ziprazidón - 68 - antipsychotica (neuroleptica)

Zypsilan 40 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zypsilan 40 mg

krka, d.d., novo mesto, slovinsko - ziprazidón - 68 - antipsychotica (neuroleptica)

Zypsilan 60 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zypsilan 60 mg

krka, d.d., novo mesto, slovinsko - ziprazidón - 68 - antipsychotica (neuroleptica)

Asolfena 5 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

asolfena 5 mg

krka, d.d., novo mesto, slovinsko - solifenacín - 73 - spasmolytica

Asolfena 10 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

asolfena 10 mg

krka, d.d., novo mesto, slovinsko - solifenacín - 73 - spasmolytica

Furosemid FMK 40 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

furosemid fmk 40 mg

farmak international sp. z o.o., poľsko - furosemid - 50 - diuretica

Trixeo Aerosphere Európska únia - slovenčina - EMA (European Medicines Agency)

trixeo aerosphere

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - pľúcna choroba, chronická obštrukcia - drogy obštrukčnej choroby dýchacích ciest, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Tabrecta Európska únia - slovenčina - EMA (European Medicines Agency)

tabrecta

novartis europharm limited  - capmatinib dihydrochloride monohydrate - karcinóm, pľúc bez malých buniek - antineoplastické činidlá - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

Sitagliptin / Metformin hydrochloride Accord Európska únia - slovenčina - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, typ 2 - lieky používané pri cukrovke - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. trojlôžkových kombinovaná liečba) ako doplnok stravy a cvičenia pacientov nedostatočne kontrolované na ich maximálna tolerovaná dávka metformín a sulfonylmocoviny. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.